PLL-g-PEG Polymer Inhibits Antibody-Drug Conjugate Uptake into Human Corneal Epithelial Cells <i>In Vitro</i>-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PLL-g-PEG Polymer Inhibits Antibody-Drug Conjugate Uptake into Human Corneal Epithelial Cells In Vitro

Published:2024-06-27 Issue: Volume: Page:
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Kleinman David¹^ORCID,Iqbal Sana²³⁴^ORCID,Ghosh Anita K.⁴⁵⁶,Ogle Sean D.⁶,Kaja Simon³⁴^ORCID,Mitchnick Mark¹,Hakkarainen Jenni J.⁷^ORCID

Affiliation:

1. Calm Water Therapeutics LLC, Rochester, New York, USA.

2. Graduate Program in Molecular Pharmacology and Therapeutics, Health Sciences Division, Loyola University Chicago, Maywood, Illinois, USA.

3. Department of Molecular Pharmacology & Neuroscience, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.

4. Department of Ophthalmology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.

5. Graduate Program in Biochemistry and Molecular Biology, Health Sciences Division, Loyola University Chicago, Maywood, Illinois, USA.

6. Research & Development Division, Experimentica Ltd, Forest Park, Illinois, USA.

7. Research & Development Division, Experimentica Ltd, Kuopio, Finland.

Publisher

Mary Ann Liebert Inc

Link

https://www.liebertpub.com/doi/pdf/10.1089/jop.2024.0019

Reference38 articles.

1. Antibody–Drug Conjugates: A Comprehensive Review

2. Antibody drug conjugate: the “biological missile” for targeted cancer therapy

3. Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates

4. Ocular Adverse Events Associated with Antibody–Drug Conjugates in Human Clinical Trials

5. Ocular Toxicity of Belantamab Mafodotin, an Oncological Perspective of Management in Relapsed and Refractory Multiple Myeloma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3